These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3830770)
21. [Results of random screening of possible antineoplastic agents in Japan using mouse cancer. 3]. Gan To Kagaku Ryoho; 1984 Sep; 11(9 Pt 2):1899-2096. PubMed ID: 6497404 [No Abstract] [Full Text] [Related]
22. Proceedings: Antitumor properties of amino acid related compounds. 3. Anti-leukemic effects of compounds with ethylcarbaminomethyl substituent. Fujita H; Fukushima K; Toyoshima S Jpn J Pharmacol; 1974; 24(0):s:35. PubMed ID: 4545744 [No Abstract] [Full Text] [Related]
23. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl. Yagi MJ; Bekesi JG Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 1. Communication: relationship between chemical structure and pharmacological action. Brock N; Kuhlmann J Arzneimittelforschung; 1974 Aug; 24(8):1139-49. PubMed ID: 4371234 [No Abstract] [Full Text] [Related]
25. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799 [TBL] [Abstract][Full Text] [Related]
26. [Experimental study of the antitumor activity and toxicity of the preparation, Peptichemio]. Balitskiĭ KP; Veksler IG; Tsapenko VF Vopr Onkol; 1979; 25(7):105. PubMed ID: 483671 [No Abstract] [Full Text] [Related]
27. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse. Yancey ST; Bleyer WA Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157 [No Abstract] [Full Text] [Related]
28. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent. Hickman JA; Stevens MF; Gibson NW; Langdon SP; Fizames C; Lavelle F; Atassi G; Lunt E; Tilson RM Cancer Res; 1985 Jul; 45(7):3008-13. PubMed ID: 4005840 [TBL] [Abstract][Full Text] [Related]
29. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy. Catsoulacos P; Catsoulacos D Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677 [TBL] [Abstract][Full Text] [Related]
30. [Experimental study of antitumor action of rubomycin in combination with some cytostatic compounds]. Rossolimo OK; Lepeshkina GN Antibiotiki; 1967 Mar; 12(3):206-12. PubMed ID: 4969789 [No Abstract] [Full Text] [Related]
32. [Determination of the kinetic parameters of tumor growth and an evaluation of the antitumor activity of chemotherapeutic preparations based on life expectancy]. Konradov AA; Dronova LM; Erokhin VN; Belich EI; Korman DB Izv Akad Nauk SSSR Biol; 1982; (3):419-27. PubMed ID: 7096779 [No Abstract] [Full Text] [Related]
34. Drug latentiation in cancer chemotherapy. Workman P; Double JA Biomedicine; 1978 Oct; 28(5):255-62. PubMed ID: 369628 [TBL] [Abstract][Full Text] [Related]
35. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction]. Arzneimittelforschung; 1974 Aug; 24(8):1149-60. PubMed ID: 4371545 [No Abstract] [Full Text] [Related]
36. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia. Trafalis DT; Tsavdaridis D; Camoutsis C; Karayiani V; Mourelatos D; Dalezis P; Athanassiou A; Pangalis GA; Papageorgiou A Br J Haematol; 2005 Feb; 128(3):343-50. PubMed ID: 15667536 [TBL] [Abstract][Full Text] [Related]
37. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models]. Gutsche W; Schulze W; Jungstand W; Wohlrabe K Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372 [TBL] [Abstract][Full Text] [Related]
39. [Effectiveness in vivo of some antiblastomic preparations in relation to cells resistant to bruneomycin and olivomycin]. Prokhorova EV Antibiotiki; 1969 Jun; 14(7):621-6. PubMed ID: 4185522 [No Abstract] [Full Text] [Related]
40. [Correlations between the chemical structure of Mannich bases with and without nitrogen mustard groups and their cytostatic effect on Ehrlich ascites carcinoma in albino mice]. Werner W; Jungstand W; Gutsche W Arzneimittelforschung; 1970 Feb; 20(2):246-9. PubMed ID: 5467470 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]